LaNova Medicines Revenue and Competitors
Estimated Revenue & Valuation
- LaNova Medicines's estimated annual revenue is currently $3.1M per year.
- LaNova Medicines's estimated revenue per employee is $155,000
- LaNova Medicines's total funding is $200M.
Employee Data
- LaNova Medicines has 20 Employees.
- LaNova Medicines grew their employee count by -5% last year.
LaNova Medicines's People
| Name | Title | Email/Phone |
|---|
LaNova Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.4M | 9 | 80% | N/A | N/A |
#2 | $1.6M | 10 | 0% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.4M | 9 | 29% | N/A | N/A |
#5 | $3.1M | 20 | -5% | $200M | N/A |
#6 | $0.8M | 5 | 25% | N/A | N/A |
#7 | $4.2M | 27 | -13% | $133M | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $8.7M | 56 | 2% | $146M | N/A |
#10 | $2.8M | 18 | 20% | $93M | N/A |
What Is LaNova Medicines?
Founded in 2019 in Shanghai, China, LaNova Medicines is a clinical-stage biotechnology company committed to the discovery and development of novel biologic drugs for cancer treatment.\n\nLed by industry veterans with a strong passion for innovation, we aim to operate as an R&D engine and deliver transformative medicines to address the unmet clinical needs of cancer patients. Leveraging our proprietary technology platforms and deep understanding of the tumor microenvironment. we have built a differentiated pipeline of products and are striving to progress our programs toward the clinic.
keywords:N/A
$200M
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Shanghai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.2M | 20 | 43% | N/A |
#2 | $3.6M | 21 | 0% | N/A |
#3 | $2.9M | 21 | 0% | N/A |
#4 | $2.9M | 21 | 0% | N/A |
#5 | $2.1M | 21 | -5% | N/A |